On 20 November the Food and Drug Administration (FDA) published a request for comments on a proposed framework for regulating the output of digital health applications disseminated by or on behalf of drug manufacturers with one or more of their prescription drugs.
Please see full publication below for more information.
LOADING PDF: If there are any problems, click here to download the file.
